Navigation Links
Pro-Dex, Inc. Announces Fiscal 2012 First Quarter Results
Date:11/9/2011

tern Time (6:30 a.m. Pacific Time) that may be accessed by visiting the Company's website at www.pro-dex.com.  The conference call may also be accessed at www.InvestorCalendar.com. Investors and analysts who would like to participate in the conference call may do so via telephone at (877) 407-8033, or at (201) 689-8033 if calling from outside the U.S.

For those who cannot access the live broadcast, a replay will be available approximately two hours after the completion of the call until midnight (Eastern Time) on November 22, 2011 by calling (877) 660-6853, or (201) 612-7415 if calling from outside the U.S., and then entering account number 286 and conference I.D. number 382391.  An online archive of the broadcast will be available on the Company's website www.pro-dex.com for a period of 365 days.

Pro-Dex, Inc., with operations in California, Oregon and Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate powered surgical device drive systems, embedded motion control and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections rela
'/>"/>

SOURCE Pro-Dex, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pro-Dex, Inc. Announces Fiscal 2012 First Quarter Financial Results Conference Call and Webcast
2. Pro-Dex, Inc. Named One of the Fastest Growing Public Companies in Orange County
3. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Results
4. Pro-Dex, Inc. Announces Fiscal 2011 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast
5. Pro-Dex, Inc. Announces Fiscal Third Quarter and Nine Month Results
6. Pro-Dex, Inc. Announces Fiscal 2011 Third Quarter Financial Results Conference Call and Webcast
7. Pro-Dex, Inc. Announces Fiscal Second Quarter and Six Month Results
8. Pro-Dex, Inc. Appoints Harold A. Hurwitz as Chief Financial Officer
9. Pro-Dex, Inc. Announces Fiscal 2010 Third Quarter Financial Results Conference Call and Webcast
10. Pro-Dex, Inc. Announces Fiscal Second Quarter 2010 Results
11. Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customers Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015  Medimetriks Pharmaceuticals, ... the second Phase III clinical study for Ozenoxacin, ... impetigo.  Medimetriks owns the exclusive U.S. rights to ... trial, conducted at 44 centers with an emphasis ... patients aged 2 months and older with a ...
(Date:7/30/2015)... Global ENT (Ear, Nose, ... USD 23.01 million in 2022, according to a new ... geriatric population, increasing prevalence of ear, nose, and throat ... among target customer base are expected serve this market ... According to estimates published by the WHO, 15% of ...
(Date:7/30/2015)... 2015  NanoSmart Pharmaceuticals, Inc., a private pharmaceutical ... Orphan Drug Designation from the Food and Drug ... uses NanoSmart,s proprietary drug delivery platform. The drug ... treatment of Ewing,s sarcoma, a rare type of ... Drug Designation on the basis of a plausible ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 2ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 3ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 4ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc. 5NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... Nutri-Force Nutrition is proud to announce the ... Miami Lakes, Florida. This new facility was designed ... customers with industry-leading quality and exceptionally efficient manufacturing ... innovative production control processes, the new facility includes ...
... 10 Stryker Corporation (NYSE: SYK ) announced ... held, software technology firm. OtisMed will focus on ... many benefits that surgeons and patients realize from Stryker,s ... OtisMed will operate as part of Stryker,s Orthopaedics Division ...
Cached Medicine Technology:Stryker Announces Agreements To Acquire Assets 2Stryker Announces Agreements To Acquire Assets 3
(Date:7/30/2015)... CA (PRWEB) , ... July ... ... recently released a video, “Beachside Nursing Center,” to announce its position as ... five-star ratings. Beachside's administrator and staff members support the CMS rating system, ...
(Date:7/30/2015)... ... July 30, 2015 , ... Zejax is a ... That Increases Training Capability , World renown body weight trainer, Paul Ziachik, ... ), that dramatically increases a person’s training capability. , The American College of ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web ... annual All-Stars Summit. Google Partners is the platform for search marketing agencies to ... support and tools necessary to run successful search marketing campaigns. Google Partners also ...
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... smiles, including lip lowering, gum contouring and surgery, as well as the patented gum ... artistry that has made him popular with many patients from around the world. , ...
(Date:7/30/2015)... ... , ... InventHelp, a leading inventor service company, announces that one ... it easy to apply lotion or medication to a hard-to-reach area. This invention is ... or medication to the back, and provides thorough coverage. The product would prevent the ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... whose conservative dress limits their exposure to sun should be ... serum levels, according to a study published by Henry Ford ... in a small study showed vitamin D levels averaging 8.5 ... to 4 ng/mL for those who wore the hijab, modest ...
... is preliminary and more trials are needed, study says , , ... results from the largest clinical trial of gene therapy for ... and more research must be done before an effective new ... we need to make it better before we launch a ...
... 15 issue of the Journal of Clinical Sleep ... Maintenance of Wakefulness Test (MWT40) is superior to a ... in adults who may be unable to maintain wakefulness ... may not be completely reliable when the strong motivation ...
... 14 A York County jury on Friday awarded $4.4 ... brain injury at birth. The award was against Piedmont Hospital. ... assigned a nurse trainee to monitor Robin Wilson, who arrived ... The nurse misread fetal heart monitoring data showing the baby ...
... potential respiratory effects, study says , , SATURDAY, Feb. 14 ... to women with asthma, U.S. researchers say. , ... in women who did and did not have asthma ... symptoms among the asthmatic women. , Dr. Jonathon A. ...
... Calif., Feb. 13 Lemon Grove Care & ... of Health,s announcement of a "AA" citation issued ... Grove.(Logo: http://www.newscom.com/cgi-bin/prnh/20090213/LA71049LOGO )"We stand by the ... CEO. "We disagree with the Department,s assessment of ...
Cached Medicine News:Health News:Arab-American women need supplement to boost dangerously low vitamin D levels 2Health News:Arab-American women need supplement to boost dangerously low vitamin D levels 3Health News:Gene Therapy Holds Promise for HIV 2Health News:Study finds that using wakefulness tests to detect daytime sleepiness in drivers may be unreliable 2Health News:Study finds that using wakefulness tests to detect daytime sleepiness in drivers may be unreliable 3Health News:Cleaning House May Be Risky for Women With Asthma 2Health News:Lemon Grove Care & Rehabilitation Center Responds to Health Department Announcement 2
Immuno-turbidimetric Assay for Protein S Antigen. Suspension of microlatex particles coated with specific antibodies....
Colorimetric Assay of Unfractionated and Low Molecular Weight Heparins by STA© Analyzers. Lyophilized, patent-pending chromogenic substate, CBS 52.44 of ~8.8 moles/vial and bovine factorXa ~2.2 ...
Substrate Plasma for Factor VII Assay by STA© Analyzers. Freeze-dried human plasma from which factor VII has been removed by selective immuno-adsorption....
Substrate Plasma for Factor XI Assay by STA© Analyzers. Freeze-dried human plasma lacking factor XI....
Medicine Products: